featured
Everolimus/Lapatinib/Capecitabine Is Effective and Safe for HER2+ Breast Cancer With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Therapeutic advances in medical oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase Ib/II Single-Arm Trial Evaluating the Combination of Everolimus, Lapatinib and Capecitabine for the Treatment of HER2-Positive Breast Cancer With Brain Metastases (TRIO-US B-09)
Ther Adv Med Oncol 2018 Dec 01;[EPub Ahead of Print], S Hurvitz, R Singh, B Adams, JA Taguchi, D Chan, RA Dichmann, A Castrellon, E Hu, J Berkowitz, A Mani, B DiCarlo, R Callahan, I Smalberg, X Wang, I Meglar, D Martinez, E Hobbs, DJ SlamonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.